Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011604 |
---|---|
Receipt number | R000013098 |
Scientific Title | Anti-tumor effect and safety of GDP therapy (gemcitabine, dexamethasone, and cisplatin) in patients with relapsed or refractory non-Hodgkin lymphoma |
Date of disclosure of the study information | 2013/09/01 |
Last modified on | 2021/08/25 16:53:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/08/30 15:49:06 | ||
2 | Update | 2019/05/17 09:49:38 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Category of Funding Organization Organization Organization Address Address Tel |
|
3 | Update | 2019/05/17 09:50:29 | Last follow-up date |
|
4 | Update | 2021/08/25 16:53:03 | Recruitment status Date of IRB |